Biotech Values

[DewDiligence]

VRUS—my hunch is the FDA is not that open-minded...

Well, well...I was able to nudge you off the fence :- )

I’m inclined to agree—i.e. I do not expect VRUS to submit an NDA in genotype-2/3 based on only the phase-2 data. However, oc631 has called everything correctly in the HCV arena to date, and he thinks this might be doable; for this reason alone, we should not dismiss the idea out of hand.